PLoS ONE (Jan 2021)

Blocking IL-10 signaling with soluble IL-10 receptor restores in vitro specific lymphoproliferative response in dogs with leishmaniasis caused by Leishmania infantum.

  • Catiule de Oliveira Santos,
  • Sidnei Ferro Costa,
  • Fabiana Santana Souza,
  • Jessica Mariane Ferreira Mendes,
  • Cristiane Garboggini Melo de Pinheiro,
  • Diogo Rodrigo de Magalhães Moreira,
  • Luciano Kalabric Silva,
  • Valeria Marçal Felix de Lima,
  • Geraldo Gileno de Sá Oliveira

DOI
https://doi.org/10.1371/journal.pone.0239171
Journal volume & issue
Vol. 16, no. 1
p. e0239171

Abstract

Read online

rIL-10 plays a major role in restricting exaggerated inflammatory and immune responses, thus preventing tissue damage. However, the restriction of inflammatory and immune responses by IL-10 can also favor the development and/or persistence of chronic infections or neoplasms. Dogs that succumb to canine leishmaniasis (CanL) caused by L. infantum develop exhaustion of T lymphocytes and are unable to mount appropriate cellular immune responses to control the infection. These animals fail to mount specific lymphoproliferative responses and produce interferon gamma and TNF-alpha that would activate macrophages and promote destruction of intracellular parasites. Blocking IL-10 signaling may contribute to the treatment of CanL. In order to obtain a tool for this blockage, the present work endeavored to identify the canine casIL-10R1 amino acid sequence, generate a recombinant baculovirus chromosome encoding this molecule, which was expressed in insect cells and subsequently purified to obtain rcasIL-10R1. In addition, rcasIL-10R1 was able to bind to homologous IL-10 and block IL-10 signaling pathway, as well as to promote lymphoproliferation in dogs with leishmaniasis caused by L. infantum.